there were also nearly 700 cases of reported patent litigation with generic companies, which on average lasted nearly three years.
geneerilisi ravimeid tootvate ettevõtetega toimus ligi 700 patendivaidlust, mille keskmine kestus oli peaaegu kolm aastat.